Related Experiment Videos
Oxidative stress during leukocyte absorption apheresis
Aki Hirayama1, Sohji Nagase, Atsushi Ueda
1Institute of Clinical Medicine, University of Tsukuba, Tsukuba City, Japan. aki-hira@md.tsukuba.ac.jp
Journal of Clinical Apheresis
|July 23, 2003
Summary
Leukocyte apheresis may increase oxidative stress by activating leukocytes, but plasma antioxidant activity recovers during treatment. This effect is most pronounced in the early stages of therapy for ulcerative colitis.
Area of Science:
- Biomedical Engineering
- Immunology
- Oxidative Stress Research
Background:
- Leukocyte apheresis activates leukocytes, potentially increasing oxidative stress.
- This process is generally avoided in extracorporeal circulation due to bioincompatibility concerns.
- The impact of leukocyte apheresis on in vivo oxidative stress requires further investigation.
Purpose of the Study:
- To evaluate changes in plasma oxidative stress during leukocyte apheresis.
- To compare the effects of two different leukocyte absorption devices on oxidative stress.
- To assess the temporal dynamics of oxidative stress markers during treatment.
Main Methods:
- Patients with ulcerative colitis undergoing leukocyte apheresis were studied.
- Plasma oxidative stress was measured using thiobarbituric acid reactive substances (TBARS) and hydroxyl radical scavenging activity (OHRI).
- Plasma samples were collected pre- and post-column during treatment with Adacolumn or Cellsorba EX devices.
Main Results:
- Hydroxyl radical signal intensities (OHRI) increased during column passage, indicating reduced scavenging activity.
- OHRI decreased by the end of the treatment, suggesting recovery of radical scavenging activity.
- Significant reductions in OHRI and TBARS were observed only in the early treatment phase; no device-specific differences were found.
Conclusions:
- Leukocyte apheresis temporarily diminishes plasma antioxidant activity but shows recovery during the procedure.
- The observed antioxidative effect is primarily limited to the early phase of the therapeutic course.
- Both Adacolumn and Cellsorba EX devices demonstrated similar effects on oxidative stress markers.